Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Lisa Levin
Several stocks are experiencing significant pre-market movements. Acumen Pharmaceuticals, PainReform, Nova LifeStyle, argenx SE, AERWINS Technologies, BridgeBio Pharma, Nuvve Holding Corp., Cadrenal Therapeutics, Edgio, and Genprex are among the gainers. BYND Cannasoft Enterprises, ViewRay, Ebix, Frequency Therapeutics, Apellis Pharmaceuticals, Minerva Surgical, Baosheng Media Group Holdings, Western Acquisition Ventures Corp., Monopar Therapeutics, and 60 Degrees Pharmaceuticals are among the losers.
July 17, 2023 | 12:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Acumen Pharmaceuticals shares surged 43.9% after presenting topline results from Phase 1 study of ACU193 for early Alzheimer's disease.
Positive clinical trial results often lead to a surge in stock prices as it indicates potential future revenue from the drug under study.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
BYND Cannasoft Enterprises shares fell 39.8% after the company reported a proposed underwritten public offering.
Public offerings often lead to a drop in stock prices due to dilution of shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100